| Primary |
| Bipolar Disorder |
41.1% |
| Depression |
11.1% |
| Bipolar I Disorder |
8.2% |
| Schizoaffective Disorder |
5.7% |
| Convulsion |
4.7% |
| Suicide Attempt |
4.1% |
| Mania |
3.2% |
| Psychotic Disorder Due To A General Medical Condition |
3.2% |
| Acute Myeloid Leukaemia |
2.5% |
| Obsessive-compulsive Disorder |
2.2% |
| Hypertension |
1.9% |
| Major Depression |
1.9% |
| Cardiomyopathy |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Schizophrenia |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
| Overdose |
1.3% |
| Affective Disorder |
0.9% |
| Anaesthesia |
0.9% |
| Agitation |
0.6% |
|
| Toxicity To Various Agents |
25.0% |
| Tremor |
9.9% |
| Renal Failure Chronic |
7.2% |
| Tubulointerstitial Nephritis |
6.6% |
| Vomiting |
6.6% |
| Syncope |
5.3% |
| Hyperparathyroidism |
3.9% |
| Renal Cyst |
3.9% |
| Renal Failure Acute |
3.3% |
| Renal Injury |
3.3% |
| Therapeutic Agent Toxicity |
3.3% |
| Urinary Tract Infection |
3.3% |
| Serotonin Syndrome |
2.6% |
| Thyroiditis |
2.6% |
| Unresponsive To Stimuli |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Delirium |
2.0% |
| Mental Status Changes |
2.0% |
| Nephrogenic Diabetes Insipidus |
2.0% |
| Renal Impairment |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
20.7% |
| Bipolar Disorder |
20.0% |
| Drug Use For Unknown Indication |
12.5% |
| Depression |
9.0% |
| Bipolar I Disorder |
5.0% |
| Schizophrenia |
4.5% |
| Schizoaffective Disorder |
4.1% |
| Psychotic Disorder |
3.1% |
| Hypertension |
2.7% |
| Suicide Attempt |
2.6% |
| Mania |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Anxiety |
1.8% |
| Mood Swings |
1.8% |
| Psychotic Disorder Due To A General Medical Condition |
1.8% |
| Sleep Disorder |
1.6% |
| Convulsion |
1.5% |
| Hypothyroidism |
1.1% |
| Bipolar Ii Disorder |
1.0% |
| Pain |
1.0% |
|
| Tremor |
11.8% |
| Weight Increased |
11.8% |
| Completed Suicide |
11.0% |
| Toxicity To Various Agents |
10.3% |
| Vomiting |
7.6% |
| Death |
5.6% |
| Serotonin Syndrome |
4.8% |
| Neuroleptic Malignant Syndrome |
4.5% |
| Weight Decreased |
4.5% |
| Therapeutic Agent Toxicity |
4.3% |
| Drug Toxicity |
3.1% |
| Overdose |
3.1% |
| Renal Impairment |
3.1% |
| Suicide Attempt |
2.7% |
| Drug Ineffective |
2.5% |
| Drug Interaction |
2.1% |
| Suicidal Ideation |
1.9% |
| Unresponsive To Stimuli |
1.9% |
| White Blood Cell Count Decreased |
1.7% |
| Poisoning |
1.6% |
|
| Concomitant |
| Bipolar Disorder |
30.4% |
| Product Used For Unknown Indication |
11.9% |
| Depression |
11.4% |
| Drug Use For Unknown Indication |
5.7% |
| Schizophrenia |
4.8% |
| Anxiety |
4.3% |
| Schizoaffective Disorder |
4.1% |
| Bipolar I Disorder |
3.8% |
| Sleep Disorder |
3.0% |
| Hypertension |
2.9% |
| Smoking Cessation Therapy |
2.8% |
| Affective Disorder |
2.2% |
| Psychotic Disorder |
2.0% |
| Insomnia |
2.0% |
| Pain |
2.0% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Mania |
1.7% |
| Hepatitis C |
1.2% |
| Asthma |
1.2% |
| Hypothyroidism |
1.1% |
|
| Weight Increased |
15.9% |
| Type 2 Diabetes Mellitus |
10.1% |
| Vomiting |
8.7% |
| Tremor |
8.4% |
| Weight Decreased |
6.3% |
| Suicidal Ideation |
5.3% |
| Somnolence |
4.8% |
| Vision Blurred |
4.6% |
| Tardive Dyskinesia |
3.8% |
| Nausea |
3.6% |
| White Blood Cell Count Decreased |
3.4% |
| Drug Ineffective |
3.3% |
| Suicide Attempt |
3.1% |
| Mania |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Rash |
2.8% |
| Granulocytopenia |
2.5% |
| Pulmonary Embolism |
2.5% |
| Insomnia |
2.4% |
| Loss Of Consciousness |
2.4% |
|
| Interacting |
| Bipolar Disorder |
39.3% |
| Product Used For Unknown Indication |
20.3% |
| Smoking Cessation Therapy |
6.3% |
| Major Depression |
5.1% |
| Schizoaffective Disorder |
4.1% |
| Mania |
3.9% |
| Schizoaffective Disorder Bipolar Type |
3.5% |
| Mood Altered |
2.9% |
| Drug Use For Unknown Indication |
2.5% |
| Depression |
2.3% |
| Headache |
1.8% |
| Hypertension |
1.6% |
| Acne |
1.0% |
| Insomnia |
1.0% |
| Pain |
1.0% |
| Cardiac Disorder |
0.8% |
| Convulsion |
0.8% |
| Hypomania |
0.8% |
| Fibromyalgia |
0.6% |
| Histrionic Personality Disorder |
0.6% |
|
| Drug Interaction |
18.1% |
| Tremor |
15.5% |
| Serotonin Syndrome |
9.5% |
| Drug Ineffective |
8.6% |
| Paranoia |
6.0% |
| Toxicity To Various Agents |
6.0% |
| Dysphemia |
3.4% |
| Emotional Distress |
3.4% |
| Rhabdomyolysis |
3.4% |
| Depression |
2.6% |
| Glomerular Filtration Rate Decreased |
2.6% |
| Neuroleptic Malignant Syndrome |
2.6% |
| Renal Failure Acute |
2.6% |
| Suicidal Ideation |
2.6% |
| Thalassaemia Beta |
2.6% |
| Therapeutic Agent Toxicity |
2.6% |
| Vomiting |
2.6% |
| Hypothyroidism |
1.7% |
| Speech Disorder |
1.7% |
| Toxic Encephalopathy |
1.7% |
|
